CAFC-DCTJune 2, 2026·26-1794·Appeal dismissed; mandate issued June 2, 2026.
MIMEDX GROUP, INC. v. SURGENEX, LLC
District Court
Holding
The Federal Circuit dismissed the appeal under Federal Rule of Appellate Procedure 42(b) based on the parties’ agreement. Each side must bear its own costs.
Why It Matters
The order is a merits-free voluntary dismissal and provides no substantive patent-law guidance.
Full Summary
MIMEDX GROUP, INC. v. SURGENEX, LLC [ORDER]
The Federal Circuit dismissed the appeal under Federal Rule of Appellate Procedure 42(b) based on the parties’ agreement. Each side must bear its own costs.
The order is a merits-free voluntary dismissal and provides no substantive patent-law guidance.
Appeal dismissed; mandate issued June 2, 2026.
The order is nonprecedential.
The Federal Circuit did not address any patent-law issue or the district court’s underlying ruling.
Dismissal was by party agreement under Rule 42(b).
The court ordered each side to bear its own costs and issued the mandate the same day.
non-precedential
non-precedential
non-precedential
Key Points
- The order is nonprecedential.
- The Federal Circuit did not address any patent-law issue or the district court’s underlying ruling.
- Dismissal was by party agreement under Rule 42(b).
- The court ordered each side to bear its own costs and issued the mandate the same day.
How this summary was made: Drafted with AI from the court's opinion or order. Read the document itself before relying on the summary. Editorial policy
New to Federal Circuit? See our Federal Circuit page